calanderBy Prof. Rautoucalander28 August 2020
Microvesicles as NAFLD biomarkers: a clinician’s point of view by Prof. P. E. Rautou

Prof Rautou, France, sheds light on microvesicles, which reflect apoptosis and cell activation. He discusses what we know about microvesicles in NASH and the rationale to consider them as biomarkers in liver disease.